Ozoralizumab
From Wikipedia, the free encyclopedia
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized |
Target | Lama glama |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 1167985-17-2 |
ATC code | None |
Chemical data | |
Formula | C1682H2608N472O538S12 |
Mol. mass | 38.43 kDa |
(what is this?) (verify) | |
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.
Ozoralizumab was developed by Pfizer Inc.
References
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.